Transcriptional Regulation of Bone Formation by the Osteoblast-Specific Transcription Factor
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Harnessing Low-Density Lipoprotein Receptor Protein 6 (LRP6) Genetic Variation and Wnt Signaling for Innovative Diagnostics in Complex Diseases
OPEN The Pharmacogenomics Journal (2018) 18, 351–358 www.nature.com/tpj REVIEW Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases Z-M Wang1,2, J-Q Luo1,2, L-Y Xu3, H-H Zhou1,2 and W Zhang1,2 Wnt signaling regulates a broad variety of processes in both embryonic development and various diseases. Recent studies indicated that some genetic variants in Wnt signaling pathway may serve as predictors of diseases. Low-density lipoprotein receptor protein 6 (LRP6) is a Wnt co-receptor with essential functions in the Wnt/β-catenin pathway, and mutations in LRP6 gene are linked to many complex human diseases, including metabolic syndrome, cancer, Alzheimer’s disease and osteoporosis. Therefore, we focus on the role of LRP6 genetic polymorphisms and Wnt signaling in complex diseases, and the mechanisms from mouse models and cell lines. It is also highly anticipated that LRP6 variants will be applied clinically in the future. The brief review provided here could be a useful resource for future research and may contribute to a more accurate diagnosis in complex diseases. The Pharmacogenomics Journal (2018) 18, 351–358; doi:10.1038/tpj.2017.28; published online 11 July 2017 INTRODUCTION signaling pathways and expressed in various target organs.1 LDLR- The Wnt1 gene was identified in 1982. Ensuing studies in related proteins 5/6 (LRP5/6) belong to this large family and Drosophila and Xenopus unveiled a highly conserved Wnt/ function as co-receptors of the Wnt/β-catenin pathway. These β-catenin pathway, namely, canonical Wnt signaling. -
Lgr5 Homologues Associate with Wnt Receptors and Mediate R-Spondin Signalling
ARTICLE doi:10.1038/nature10337 Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling Wim de Lau1*, Nick Barker1{*, Teck Y. Low2, Bon-Kyoung Koo1, Vivian S. W. Li1, Hans Teunissen1, Pekka Kujala3, Andrea Haegebarth1{, Peter J. Peters3, Marc van de Wetering1, Daniel E. Stange1, Johan E. van Es1, Daniele Guardavaccaro1, Richard B. M. Schasfoort4, Yasuaki Mohri5, Katsuhiko Nishimori5, Shabaz Mohammed2, Albert J. R. Heck2 & Hans Clevers1 The adult stem cell marker Lgr5 and its relative Lgr4 are often co-expressed in Wnt-driven proliferative compartments. We find that conditional deletion of both genes in the mouse gut impairs Wnt target gene expression and results in the rapid demise of intestinal crypts, thus phenocopying Wnt pathway inhibition. Mass spectrometry demonstrates that Lgr4 and Lgr5 associate with the Frizzled/Lrp Wnt receptor complex. Each of the four R-spondins, secreted Wnt pathway agonists, can bind to Lgr4, -5 and -6. In HEK293 cells, RSPO1 enhances canonical WNT signals initiated by WNT3A. Removal of LGR4 does not affect WNT3A signalling, but abrogates the RSPO1-mediated signal enhancement, a phenomenon rescued by re-expression of LGR4, -5 or -6. Genetic deletion of Lgr4/5 in mouse intestinal crypt cultures phenocopies withdrawal of Rspo1 and can be rescued by Wnt pathway activation. Lgr5 homologues are facultative Wnt receptor components that mediate Wnt signal enhancement by soluble R-spondin proteins. These results will guide future studies towards the application of R-spondins for regenerative purposes of tissues expressing Lgr5 homologues. The genes Lgr4, Lgr5 and Lgr6 encode orphan 7-transmembrane 4–5 post-induction onwards. -
Large-Scale Serum Protein Biomarker Discovery in Duchenne Muscular Dystrophy
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy Yetrib Hathouta, Edward Brodyb, Paula R. Clemensc,d, Linda Cripee, Robert Kirk DeLisleb, Pat Furlongf, Heather Gordish- Dressmana, Lauren Hachea, Erik Henricsong, Eric P. Hoffmana, Yvonne Monique Kobayashih, Angela Lortsi, Jean K. Mahj, Craig McDonaldg, Bob Mehlerb, Sally Nelsonk, Malti Nikradb, Britta Singerb, Fintan Steeleb, David Sterlingb, H. Lee Sweeneyl, Steve Williamsb, and Larry Goldb,1 aResearch Center for Genetic Medicine, Children’s National Medical Center, Washington, DC 20012; bSomaLogic, Inc., Boulder, CO 80301; cNeurology Service, Department of Veteran Affairs Medical Center, Pittsburgh, PA 15240; dUniversity of Pittsburgh, Pittsburgh, PA 15213; eThe Heart Center, Nationwide Children’s Hospital, The Ohio State University, Columbus, OH 15213; fParent Project Muscular Dystrophy, Hackensack, NJ 07601; gDepartment of Physical Medicine and Rehabilitation, University of California Davis School of Medicine, Davis, CA 95618; hDepartment of Cellular and Integrative Physiology, Indiana University School of Medicine, Indianapolis, IN 46202; iThe Heart Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229; jDepartment of Pediatrics, University of Calgary, Alberta Children’s Hospital, Calgary, AB, Canada T3B 6A8; kDivision of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO 80045; and lDepartment of Pharmacology & Therapeutics, University of Florida College of Medicine, Gainesville, FL 32610 Contributed -
Recombinant Human Dkk-1 Catalog Number: 5439-DK
Recombinant Human Dkk-1 Catalog Number: 5439-DK DESCRIPTION Source Spodoptera frugiperda, Sf 21 (baculovirus)derived human Dkk1 protein Thr32His266 Accession # O94907 Nterminal Sequence Thr32 Analysis Predicted Molecular 25.8 kDa Mass SPECIFICATIONS SDSPAGE 3338 kDa, reducing conditions Activity Measured by its ability to inhibit Wnt induced TCF reporter activity in HEK293 human embryonic kidney cells. Recombinant Human Dkk1 (Catalog # 5439DK) inhibits a constant dose of 500 ng/mL of Recombinant Human Wnt3a (Catalog # 5036WN). The ED50 for this effect is 1060 ng/mL. Endotoxin Level <1.0 EU per 1 μg of the protein by the LAL method. Purity >95%, by SDSPAGE with silver staining. Formulation Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein. See Certificate of Analysis for details. PREPARATION AND STORAGE Reconstitution Reconstitute at 100 μg/mL in PBS containing at least 0.1% human or bovine serum albumin. Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. Stability & Storage Use a manual defrost freezer and avoid repeated freezethaw cycles. l 12 months from date of receipt, 20 to 70 °C as supplied. l 1 month, 2 to 8 °C under sterile conditions after reconstitution. l 3 months, 20 to 70 °C under sterile conditions after reconstitution. DATA Bioactivity SDSPAGE Recombinant Human Wnt3a 1 μg/lane of Recombinant Human Dkk1 was (Catalog # 5036WN) induces a resolved with SDSPAGE under reducing (R) dose responsive increase in Wnt conditions and visualized by silver staining, reporter activity in HEK293 cells showing major bands at 3338 kDa. -
Dickkopf-1 (DKK1) Reveals That Fibronectin Is a Major Target of Wnt Signaling in Branching Morphogenesis of the Mouse Embryonic Lung
CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Developmental Biology 277 (2005) 316–331 www.elsevier.com/locate/ydbio Dickkopf-1 (DKK1) reveals that fibronectin is a major target of Wnt signaling in branching morphogenesis of the mouse embryonic lung Stijn P. De Langhea, Fre´de´ric G. Salaa, Pierre-Marie Del Morala, Timothy J. Fairbanksa, Kenneth M. Yamadab, David Warburtona, Robert C. Burnsa, Saverio Belluscia,* aDevelopmental Biology Program, Department of Surgery, USC Keck School of Medicine and the Saban Research Institute of Children’s Hospital Los Angeles, Los Angeles, CA 90027, USA bCraniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA Received for publication 6 April 2004, revised 16 September 2004, accepted 20 September 2004 Available online 22 October 2004 Abstract Members of the Dickkopf (Dkk) family of secreted proteins are potent inhibitors of Wnt/h-catenin signaling. In this study we show that Dkk1, -2, and -3 are expressed distally in the epithelium, while Kremen1, the needed co-receptor, is expressed throughout the epithelium of the developing lung. Using TOPGAL mice [DasGupta, R., Fuchs, E., 1999. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 126, 4557–4568] to monitor the Wnt pathway, we show that canonical Wnt signaling is dynamic in the developing lung and is active throughout the epithelium and in the proximal smooth muscle cells (SMC) until E12.5. However, from E13.5 onwards, TOPGAL activity is absent in the SMC and is markedly reduced in the distal epithelium coinciding with the onset of Dkk-1 expression in the distal epithelium. -
Acemannan Stimulates Bone Sialoprotein, Osteocalcin, Osteopon- Tin and Osteonectin Expression in Periodontal Ligament Cells in V
Original Article บ ท วิ ท ย า ก า ร Acemannan Stimulates Bone Sialoprotein, Osteocalcin, Osteopon- tin and Osteonectin Expression in Periodontal Ligament Cells in Vitro Pintu-on Chantarawaratit1,2,4, Polkit Sangvanich3 and Pasutha Thunyakitpisal2,4 1Department of Orthodontics, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand 2Dental Biomaterials Program, Graduate School, Chulalongkorn University, Bangkok, Thailand 3Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok, Thailand 4Research Unit of Herbal Medicine and Natural Products of Dental Application, Department of Anatomy, Faculty of Dentistry, Chulalongkorn University, Bangkok, Thailand Correspondence to: Pasutha Thunyakitpisal, Department of Anatomy, Faculty of Dentistry, Chulalongkorn University, 34, Henri-Dunant Rd, Patumwan, Bangkok 10330, Thailand Email: [email protected] Abstract The periodontium is composed of both soft and hard tissues, thus hard tissue regeneration is one of the most important processes in periodontal regeneration. Bone sialoprotein, osteocalcin, osteopontin and osteonectin are non- collagenous matrix proteins which play vital roles in the mineralization of hard tissue. Recent studies have demonstrated that acemannan, a polysaccharide extracted from Aloe vera gel, upregulated the expression of proteins involved in hard tissue regeneration. This study investigated effect of acemannan on bone sialoprotein, osteocalcin, osteopontin and osteonectin expression in human periodontal ligament cells. Primary periodontal ligament cells were isolated from impacted third molars and then treated with acemannan in vitro. The mRNA expression of bone sialoprotein and osteocalcin and the protein levels of osteopontin and osteonectin were determined using reverse transcription-polymerase chain reaction and western blot analysis, respectively. One-way analysis of variance and Dunnett multiple comparisons were performed to analyze the data. -
CHAPTER 41 Target Genes: Bone Proteins 719
CHAPTER 41 Target Genes: Bone Proteins 719 45. Bellows CG, Reimers SM, Heersche JN 1999 Expression of 61. Price PA, Williamson MK, Lothringer JW 1981 Origin of the mRNAs for type-I collagen, bone sialoprotein, osteocalcin, vitamin K-dependent bone protein found in plasma and its and osteopontin at different stages of osteoblastic differentia- clearance by kidney and bone. J Biol Chem 256:12760–12766. tion and their regulation by 1,25-dihydroxyvitamin D3. Cell 62. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Tissue Res 297:249–259. Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, 46. Broess M, Riva A, Gerstenfeld LC 1995 Inhibitory effects of Karsenty G 1996 Increased bone formation in osteocalcin- 1,25(OH)2 vitamin D3 on collagen type I, osteopontin, and deficient mice. Nature 382:448–452. osteocalcin gene expression in chicken osteoblasts. J Cell 63. Chenu C, Colucci S, Grano M, Zigrino P, Barattolo R, Biochem 57:440–451. Zambonin G, Baldini N, Vergnaud P, Delmas PD, Zallone AZ 47. Yoon K, Buenaga R, Rodan GA, Prince CW, Butler WT 1994 Osteocalcin induces chemotaxis, secretion of matrix pro- 1987 Tissue specificity and developmental expression of teins, and calcium-mediated intracellular signaling in human rat osteopontin. Biochem Biophys Res Commun 148: osteoclast-like cells. J Cell Biol 127:1149–1158. 1129–1136. 64. Watts NB 1999 Clinical utility of biochemical markers of bone 48. Beresford JN, Joyner CJ, Devlin C, Triffitt JT 1994 The effects remodeling. Clin Chem 45:1359–1368. of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic 65. -
Method for Predicting the Occurence of Lung Metastasis in Breast Cancer Patients
(19) TZZ ¥ __T (11) EP 2 253 721 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 24.11.2010 Bulletin 2010/47 C12Q 1/68 (2006.01) (21) Application number: 10175619.5 (22) Date of filing: 26.02.2008 (84) Designated Contracting States: (72) Inventors: AT BE BG CH CY CZ DE DK EE ES FI FR GB GR • Lidereau, Rosette HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT 92230, Gennevilliers (FR) RO SE SI SK TR • Driouch, Keltouma Designated Extension States: 93260, Les Lilas (FR) AL BA MK RS • Landemaine, Thomas 92100, Boulogne-Billancourt (FR) (30) Priority: 26.02.2007 EP 07300823 (74) Representative: Catherine, Alain et al (62) Document number(s) of the earlier application(s) in Cabinet Harlé & Phélip accordance with Art. 76 EPC: 7 rue de Madrid 08709219.3 / 2 115 170 75008 Paris (FR) (71) Applicants: Remarks: • INSERM (Institut National de la Santé et de la This application was filed on 07-09-2010 as a Recherche Medicale) divisional application to the application mentioned 75013 Paris (FR) under INID code 62. • Centre Rene Huguenin 92210 Saint-Cloud (FR) (54) Method for predicting the occurence of lung metastasis in breast cancer patients (57) The present invention relates to the prognosis tasis in one or more tissue or organ of patients affected of the progression of breast cancer in a patient, and more with a breast cancer. particularly to the prediction of the occurrence of metas- EP 2 253 721 A1 Printed by Jouve, 75001 PARIS (FR) EP 2 253 721 A1 Description FIELD OF THE INVENTION 5 [0001] The present invention relates to the prognosis of the progression of breast cancer in a patient, and more particularly to the prediction of the occurrence of metastasis in one or more tissue or organ of patients affected with a breast cancer. -
2598 Biomineralization of Bone: a Fresh View of the Roles of Non-Collagen
[Frontiers in Bioscience 16, 2598-2621, June 1, 2011] Biomineralization of bone: a fresh view of the roles of non-collagenous proteins Jeffrey Paul Gorski1 1Center of Excellence in the Study of Musculoskeletal and Dental Tissues and Dept. of Oral Biology, Sch. Of Dentistry, Univ. of Missouri-Kansas City, Kansas City, MO 64108 TABLE OF CONTENTS 1. Abstract 2. Introduction 3. Proposed mechanisms of mineral nucleation in bone 3.1. Biomineralization Foci 3.2. Calcospherulites 3.3. Matrix vesicles 4. The role of individual non-collagenous proteins 4.1. Bone Sialoprotein 4.2. Noggin 4.3. Chordin 4.4. Osteopontin 4.5. Osteopontin, bone sialoprotein, and DMP1 form individual complexes with MMPs 4.6. Bone acidic glycoprotein-75 4.7. Dentin matrix protein1 4.8. Osteocalcin 4.9. Fetuin (alpha2HS-glycoprotein) 4.10. Periostin 4.11. Tissue nonspecific alkaline phosphatase 4.12. Phospho 1 phosphatase 4.13. Ectonucleotide pyrophosphatase/phosphodiesterase 4.14. Biological effects of hydroxyapatite on bone matrix proteins 4.15. Sclerostin 4.16. Tenascin C 4.17. Phosphate-regulating neutral endopeptidase (PHEX) 4.18. Matrix extracellular phosphoglycoprotein (MEPE, OF45) 4.19. Functional importance of proteolysis in activation of transglutaminase and PCOLCE 4.20. Neutral proteases in bone 5. Summary and Perspective 6. Acknowledgements 7. References 1. ABSTRACT The impact of genetics has dramatically affected nteractions which act in positive and negative ways to our understanding of the functions of non-collagenous regulate the process of bone mineralization. Several new proteins. Specifically, mutations and knockouts have examples from the author’s laboratory are provided defined their cellular spectrum of actions. -
Chemical Properties Biological Description Solubility Information
Data Sheet (Cat.No.T0947) Dexamethason acetate Chemical Properties CAS No.: 1177-87-3 Formula: C24H31FO6 Molecular Weight: 434.51 Appearance: Solid Storage: 0-4℃ for short term (days to weeks), or -20℃ for long term (months). Biological Description Description Dexamethasone Acetate is the acetate salt form of Dexamethasone, a synthetic adrenal corticosteroid with potent anti-inflammatory properties. In addition to binding to specific nuclear steroid receptors, dexamethasone also interferes with NF-kB activation and apoptotic pathways. This agent lacks the salt-retaining properties of other related adrenal hormones. Targets(IC50) Annexin A1: None Glucocorticoid Receptor: None IL receptor: None iNOS: None In vitro Dexamethasone inhibits COX-2 mRNA expression induced by IL-1 in human articular chondrocytes. [1] Dexamethasone suppresses the cyclooxygenase-2 induction by tumor necrosis factor α (TNFα) with an IC50 of 1 nM in MC3T3-E1 cells. Dexamethasone binds to the glucocorticoid receptor and then to the glucocorticoid response element. [2]Dexamethasone (10 μM) induces osteoblastic differentiation of rat bone marrow stromal cell cultures with elevated mRNA expression of alkaline phosphatase osteopontin, bone sialoprotein, and osteocalcin. [3] Dexamethasone (5 μM) treatment decreases proliferation of adult hippocampal neural progenitor cells and SRE-driven gene expression. [5] In vivo Dexamethasone (2 mg/kg) reduces the number of the BrdU-labeled hepatocytes by 80% in male Fischer F344 rats. Dexamethasone (2 mg/kg) pretreatment suppresses the expression of both TNF and IL-6 after partial hepatectomy and significantly reduces the proliferative response of the hepatocytes in male Fischer F344 rats. Dexamethasone also severely diminishes the induction and expansion of oval cells induced by the 2- acetylaminofluorene/partial hepatectomy (AAF/PH) protocol but does not have any effect on the proliferation of the bile duct cells stimulated by bile duct ligation. -
Structural Characterization and Association of Ovine Dickkopf-1 Gene with Wool Production and Quality Traits in Chinese Merino
G C A T T A C G G C A T genes Article Structural Characterization and Association of Ovine Dickkopf-1 Gene with Wool Production and Quality Traits in Chinese Merino Fang Mu 1,†, Enguang Rong 1,†, Yang Jing 1, Hua Yang 2, Guangwei Ma 1, Xiaohong Yan 1, Zhipeng Wang 1, Yumao Li 1, Hui Li 1 and Ning Wang 1,* 1 Key Laboratory of Chicken Genetics and Breeding at Ministry of Agriculture, Key Laboratory of Animal Genetics, Breeding and Reproduction at Education Department of Heilongjiang Province, Key Laboratory of Animal Cellular and Genetic Engineering of Heilongjiang Province, Harbin 150030, China; [email protected] (F.M.); [email protected] (E.R.); [email protected] (Y.J.); [email protected] (G.M.); [email protected] (X.Y.); [email protected] (Z.W.); [email protected] (Y.L.); [email protected] (H.L.) 2 Institute of Animal Husbandry and Veterinary, Xinjiang Academy of Agriculture and Reclamation Science, Shihezi 832000, China; [email protected] * Correspondence: [email protected]; Tel.: +86-0451-5519-1770 † These authors contributed equally to this work. Received: 20 October 2017; Accepted: 15 December 2017; Published: 20 December 2017 Abstract: Dickkopf-1 (DKK1) is an inhibitor of canonical Wnt signaling pathway and regulates hair follicle morphogenesis and cycling. To investigate the potential involvement of DKK1 in wool production and quality traits, we characterized the genomic structure of ovine DKK1, performed polymorphism detection and association analysis of ovine DKK1 with wool production and quality traits in Chinese Merino. Our results showed that ovine DKK1 consists of four exons and three introns, which encodes a protein of 262 amino acids. -
CNN1 Regulates the DKK1/Wnt/Β‑Catenin/C‑Myc Signaling Pathway by Activating TIMP2 to Inhibit the Invasion, Migration and EMT of Lung Squamous Cell Carcinoma Cells
EXPERIMENTAL AND THERAPEUTIC MEDICINE 22: 855, 2021 CNN1 regulates the DKK1/Wnt/β‑catenin/c‑myc signaling pathway by activating TIMP2 to inhibit the invasion, migration and EMT of lung squamous cell carcinoma cells WUSHENG LIU1, XIAOGANG FU2 and RUMEI LI3 1Department of Respiratory Medicine, The Affiliated Xinyu Hospital of Nanchang University; Departments of 2Respiratory Medicine and 3Endocrinology, Xinyu People's Hospital, Xinyu, Jiangxi 338000, P.R. China Received October 23, 2020; Accepted February 12, 2021 DOI: 10.3892/etm.2021.10287 Abstract. The present study aimed to investigate the effect tumors has increased over the last decades and this type of of calponin 1 (CNN1) on the invasion and migration of lung cancer is responsible for >1.3 million deaths worldwide annu‑ squamous cell carcinoma (LUSC) cells and the associations ally (1). Lung tumors are one of the most frequent malignant between CNN1, tissue inhibitor of metalloproteinases 2 tumors types in China (2,3). Lung cancer is mainly divided (TIMP2), Dickkopf‑1 (DKK1) and the Wnt/β‑catenin/c‑myc into non‑small cell lung cancer (NSCLC) and small cell lung signaling pathway. The expression levels of CNN1 and cancer, with NSCLC accounting for ~80% of all cases (4). TIMP2 in LUSC cells and the association between CNN1 The two main subtypes of NSCLC are lung adenocarcinoma and TIMP2 were predicted using the GEPIA database. The and lung squamous cell carcinoma (LUSC), and LUSC is cells were transiently transfected to overexpress CNN1, which insidious and develops rapidly (5). A subset of patients with resulted in inhibition of DKK1 and TIMP2 expression levels.